Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.49 |
| ▸ | NAMPT | P43490 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7958303 | 0.85 | NR3C2 (0.53) | POLBLMNAL3MBTL1SMN1; SMN2HTT | |
| SCHEMBL7956456 | 0.84 | RAB9A (0.49) | POLBLMNAL3MBTL1SMN1; SMN2ALDH1A1 | |
| SCHEMBL7956237 | 0.80 | GAA (0.44) | POLBLMNAL3MBTL1SMN1; SMN2NAMPT | |
| SCHEMBL7958990 | 0.80 | ALDH1A1 (0.60) | POLBLMNASMN1; SMN2NAMPTHTT | |
| SCHEMBL7956813 | 0.77 | GAA (0.50) | POLBLMNAL3MBTL1SMN1; SMN2NAMPT | |
| SCHEMBL5166003 | 0.76 | SMN1; SMN2 (0.60) | LMNAL3MBTL1SMN1; SMN2ALDH1A1 | |
| SCHEMBL7956461 | 0.73 | ALDH1A1 (0.54) | POLBLMNASMN1; SMN2HTTALDH1A1 | |
| SCHEMBL5167263 | 0.72 | SMN1; SMN2 (0.56) | LMNAL3MBTL1SMN1; SMN2NAMPTALDH1A1 | |
| SCHEMBL5892016 | 0.72 | CYP19A1 (0.57) | LMNAL3MBTL1SMN1; SMN2ALDH1A1 | |
| SCHEMBL27083314 | 0.72 | POLB (0.61) | POLBLMNAL3MBTL1SMN1; SMN2NAMPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6313127-B1 | FOR THERAPY OF HYPERCHOLESTEROLEMIA OR ATHEROSCLEROSIS | ZENECA LIMITED (GB) | 2001-11-06 | — | — | US | disclosed |
| EP-0880501-A1 | HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS | ZENECA LIMITED (GB) | 1998-12-02 | — | — | EP | disclosed |
| WO-1997028128-A1 | HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS | ZENECA LIMITED (GB) | 1997-08-07 | — | — | WO | disclosed |